Morant Trade Complicates Future for Israeli Star Deni Avdija in Portland
The recent trade that brought point guard Ja Morant to the Portland Trail Blazers could significantly impact Israeli player Deni Avdija's future with the team, both for the upcoming season and regarding his potential new contract. Concerns have been raised about Morant's fit within the Blazers' future roster, with some suggesting Portland should have prioritized building around Avdija's All-Star potential.
According to blogger Reese Kunz, the acquisition of Morant presents two main issues. Firstly, Morant, a 30% three-point shooter, is expected to reduce spacing for Avdija and take the ball out of his hands. Secondly, Morant's contract, worth $87 million over the next two years, complicates Portland's ability to retain Avdija. Instead of creating financial flexibility to offer Avdija a contract commensurate with his status, potentially a maximum deal, the team has added another high-salary player.
Kunz noted that while the trade sending Jerami Grant to Memphis was theoretically sound in its attempt to raise the team's potential ceiling, Morant himself might have been the wrong choice. The Blazers did not make an "all-or-nothing" move that would sacrifice their promising future for a ceiling that doesn't yet rival championship contenders. From this perspective, the deal isn't necessarily a disaster.
However, significant questions remain about whether the risks to Avdija's development and his potential free agency in 2028 justify the gamble on Morant's resurgence. Furthermore, the defensive identity of the team could be compromised by a backcourt featuring Morant and Damian Lillard. These uncertainties leave many questions for first-year coach Chauncey Billups as the team navigates this new landscape.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.